Physician profile
Mark A Kroll
NPI 1568494136
$3,743.69
in general payments reported to CMS, 2019-2025
18 companies · $762 in 2025
The $762 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $551 · 2021: $928 · 2022: $395 · 2023: $317 · 2024: $482 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,561.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $733.83 | 2019-2025 | Clareon, Voyager Dslt, Hydrus Microstent |
| Allergan, INC. | $726.72 | 2019-2022 | |
| Biotissue Holdings INC. | $579.21 | 2024-2025 | |
| Abbvie INC. | $429.12 | 2022-2025 | |
| Carl Zeiss Meditec USA, INC. | $318.48 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $200.53 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $187.64 | 2019-2022 | |
| Glaukos Corporation | $126.69 | 2019-2024 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Aerie Pharmaceuticals, INC. | $106.64 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.82 | 2019-2021 | |
| Rxsight INC | $68.59 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Eyevance Pharmaceuticals LLC | $32.46 | 2019-2020 | |
| Coopervision INC. | $25.23 | 2025 | Myday Contact Lens |
| Ocular Therapeutix, INC. | $24.56 | 2025 | Dextenza |
| Horizon Therapeutics Plc | $24.26 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $23.78 | 2023 | |
| Rayner Intraocular Lenses Limited | $19.43 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Kala Pharmaceuticals, INC. | $16.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.